{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:08:01Z","timestamp":1789243681337,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019176","name":"Shenzhen Institute of Synthetic Biology","doi-asserted-by":"publisher","award":["ZTXM20214005"],"award-info":[{"award-number":["ZTXM20214005"]}],"id":[{"id":"10.13039\/100019176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025A1515011991"],"award-info":[{"award-number":["2025A1515011991"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFA0906003"],"award-info":[{"award-number":["2019YFA0906003"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009019","name":"Shenzhen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014173","name":"Health and Family Planning Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["SZSM202011017SZ"],"award-info":[{"award-number":["SZSM202011017SZ"]}],"id":[{"id":"10.13039\/501100014173","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.intimp.2026.116719","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T10:02:03Z","timestamp":1778061723000},"page":"116719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MFAP4 activates PI3K\/AKT\u2013NF-\u03baB signaling to drive tumor progression and immune evasion in bladder cancer"],"prefix":"10.1016","volume":"182","author":[{"given":"Yingchen","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YingQi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Yangyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangxian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiren","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2026.116719_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.intimp.2026.116719_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030566","article-title":"Current and future landscape of perioperative treatment for muscle-invasive bladder cancer","volume":"15","author":"Esteban-Villarrubia","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.intimp.2026.116719_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskj\u00f8t","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6","key":"10.1016\/j.intimp.2026.116719_bb0020","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/annonc\/mdz127","article-title":"Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up","volume":"30","author":"Fradet","year":"2019","journal-title":"Ann. Oncol."},{"issue":"12","key":"10.1016\/j.intimp.2026.116719_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103972","article-title":"Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial","volume":"9","author":"Rosenberg","year":"2024","journal-title":"ESMO Open"},{"issue":"4","key":"10.1016\/j.intimp.2026.116719_bb0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.7444","article-title":"Immune checkpoint inhibitors and long-term survival of patients with metastatic urothelial cancer","volume":"6","author":"Zhu","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"9","key":"10.1016\/j.intimp.2026.116719_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-06119-x","article-title":"Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications","volume":"14","author":"Fang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.116719_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-022-01704-8","article-title":"M6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion","volume":"22","author":"Cao","year":"2023","journal-title":"Mol. Cancer"},{"issue":"8049","key":"10.1016\/j.intimp.2026.116719_bb0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41586-024-08439-0","article-title":"Immune evasion through mitochondrial transfer in the tumour microenvironment","volume":"638","author":"Ikeda","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.116719_bb0050","doi-asserted-by":"crossref","unstructured":"Kanaan R, Medlej-Hashim M, Jounblat R, et al. Microfibrillar-associated protein 4 in health and disease. Matrix Biol., 2022, 111: 1\u201325.","DOI":"10.1016\/j.matbio.2022.05.008"},{"issue":"3","key":"10.1016\/j.intimp.2026.116719_bb0055","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ymthe.2025.01.038","article-title":"Pharmacological blocking of microfibrillar-associated protein 4 reduces retinal neoangiogenesis and vascular leakage","volume":"33","author":"Schlosser","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.intimp.2026.116719_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1551863","article-title":"MFAP4 is a novel prognostic biomarker in glioma correlating with immunotherapy resistance and ferroptosis","volume":"16","author":"Lv","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116719_bb0065","article-title":"Screening drugs of anemoside b4 for MFAP4 expression in osteosarcoma in PDTX to increase personalized medicine","volume":"16","author":"Zhang","year":"2025","journal-title":"Discov. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116719_bb0070","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7150\/jca.28127","article-title":"High expression levels of AGGF1 and MFAP4 predict primary platinum-based chemoresistance and are associated with adverse prognosis in patients with serous ovarian cancer","volume":"10","author":"Zhao","year":"2019","journal-title":"J. Cancer"},{"issue":"8","key":"10.1016\/j.intimp.2026.116719_bb0075","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/s41590-024-01896-9","article-title":"T cell dysfunction and therapeutic intervention in cancer","volume":"25","author":"Zebley","year":"2024","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116719_bb0080","article-title":"Immune checkpoint molecules: a review on pathways and immunotherapy implications","volume":"13","author":"Rezazadeh-Gavgani","year":"2025","journal-title":"Immunity Inflamm. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.116719_bb0085","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.116719_bb0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","article-title":"Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.116719_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16010131","article-title":"Current landscape of immune checkpoint inhibitors for metastatic urothelial carcinoma: is there a role for additional t-cell blockade?","volume":"16","author":"Ogbuji","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.intimp.2026.116719_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030922","article-title":"CD155: a multi-functional molecule in tumor progression","volume":"21","author":"Molfetta","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116719_bb0105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-020-00913-2","article-title":"CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma","volume":"13","author":"Lupo","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116719_bb0110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41419-025-07857-w","article-title":"Exploring the involvement of serine proteases in neutrophil extracellular traps: a review of mechanisms and implications","volume":"16","author":"Korba-Miko\u0142ajczyk","year":"2025","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.intimp.2026.116719_bb0115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.intimp.2026.116719_bb0120","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/14728222.2024.2389203","article-title":"The emerging role of tetraspanin 32 in autoimmune diseases: from discovery to relevant theranostics?","volume":"28","author":"Fagone","year":"2024","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.intimp.2026.116719_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.699895","article-title":"TIGIT, the next step towards successful combination immune checkpoint therapy in cancer","volume":"12","author":"Ge","year":"2021","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116719_bb0130","doi-asserted-by":"crossref","first-page":"14250","DOI":"10.1096\/fj.202001026R","article-title":"MFAP4 deficiency alleviates renal fibrosis through inhibition of NF-\u03baB and TGF-\u03b2\/smad signaling pathways","volume":"34","author":"Pan","year":"2020","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.intimp.2026.116719_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2025.101548","article-title":"MFAP4 deficiency attenuates liver fibrosis by regulating hepatic stellate cell fate through inhibition of the FAK\/PI3K\/NF\u03baB signaling pathway","volume":"19","author":"Liu","year":"2025","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116719_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020355","article-title":"NF-\u03baB in cancer immunity: friend or foe?","volume":"10","author":"Lalle","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.intimp.2026.116719_bb0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13578-021-00677-3","article-title":"AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K\/AKT\/NF-\u03baB signaling pathway","volume":"11","author":"Qu","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.intimp.2026.116719_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.01222","article-title":"Gallic acid inhibits bladder cancer t24 cell progression through mitochondrial dysfunction and PI3K\/Akt\/NF-\u03baB signaling suppression","volume":"11","author":"Zeng","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116719_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004711","article-title":"TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy","volume":"10","author":"Chiang","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.116719_bb0160","article-title":"Predicting atezolizumab response in metastatic urothelial carcinoma patients using machine learning on integrated tumour gene expression and clinical data","volume":"9","author":"Piyawajanusorn","year":"2025","journal-title":"Npj. Precis. Oncol."},{"key":"10.1016\/j.intimp.2026.116719_bb0165","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2147\/OTT.S369043","article-title":"Immunotherapy for urothelial carcinoma: focus on clinical utility of nivolumab","volume":"15","author":"Chiang","year":"2022","journal-title":"Onco. Targets Ther."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926005655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926005655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:54:24Z","timestamp":1789242864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926005655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":33,"alternative-id":["S1567576926005655"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116719","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MFAP4 activates PI3K\/AKT\u2013NF-\u03baB signaling to drive tumor progression and immune evasion in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116719"}}